image
Technology - Hardware, Equipment & Parts - NASDAQ - US
$ 1.63
3.82 %
$ 55.4 M
Market Cap
-54.33
P/E
1. INTRINSIC VALUE

Luna Innovations Incorporated develops, manufactures, and markets fiber optic test, measurement, and control products worldwide. The company offers optical test and measurement products, which include optical vector analyzer, optical backscatter reflectometers, and the Phoenix family of tunable lasers; and Hyperion sensing solution that enables full-spectrum data acquisition and flexible peak detect algorithms of fiber-bragg gratings (FBGs), long period FBGs, and fabry-perot sensors with low-latency access to data for closed loop feedback applications. It also provides polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; single frequency lasers; temperature and strain sensing products; ODiSI sensing solution, which provides distributed strain and temperature measurements; and Terametrix terahertz gauging and imaging products that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements, as well as distributed acoustic sensing intellectual property and products.[ Read More ]

The intrinsic value of one LUNA stock under the base case scenario is HIDDEN Compared to the current market price of 1.63 USD, Luna Innovations Incorporated is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart LUNA

image
FINANCIALS
109 M REVENUE
25.12%
-1.88 M OPERATING INCOME
27.26%
-570 K NET INCOME
-41.24%
-8.57 M OPERATING CASH FLOW
-191.10%
-11.1 M INVESTING CASH FLOW
-525.28%
9.51 M FINANCING CASH FLOW
852.53%
30.7 M REVENUE
5.28%
1.15 M OPERATING INCOME
638.32%
461 K NET INCOME
128.88%
2.33 M OPERATING CASH FLOW
139.05%
-602 K INVESTING CASH FLOW
17.87%
1.09 M FINANCING CASH FLOW
-82.97%
Balance Sheet Decomposition Luna Innovations Incorporated
image
Current Assets 87.9 M
Cash & Short-Term Investments 6.02 M
Receivables 40.9 M
Other Current Assets 40.9 M
Non-Current Assets 63.1 M
Long-Term Investments 0
PP&E 9.55 M
Other Non-Current Assets 53.6 M
Current Liabilities 33.6 M
Accounts Payable 8.11 M
Short-Term Debt 4.79 M
Other Current Liabilities 20.7 M
Non-Current Liabilities 24 M
Long-Term Debt 23.6 M
Other Non-Current Liabilities 346 K
EFFICIENCY
Earnings Waterfall Luna Innovations Incorporated
image
Revenue 109 M
Cost Of Revenue 43 M
Gross Profit 66.5 M
Operating Expenses 68.4 M
Operating Income -1.88 M
Other Expenses -1.31 M
Net Income -570 K
RATIOS
60.73% GROSS MARGIN
60.73%
-1.72% OPERATING MARGIN
-1.72%
8.47% NET MARGIN
8.47%
9.93% ROE
9.93%
6.14% ROA
6.14%
-1.47% ROIC
-1.47%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Luna Innovations Incorporated
image
Net Income -570 K
Depreciation & Amortization 5.45 M
Capital Expenditures -2.94 M
Stock-Based Compensation 4.23 M
Change in Working Capital -15.4 M
Others -2.26 M
Free Cash Flow -11.5 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Luna Innovations Incorporated
image
LUNA has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Luna Innovations Incorporated
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
5 years ago
Sep 04, 2019
Sell 453 K USD
Carilion Clinic
10 percent owner
- 71701
6.32 USD
5 years ago
Sep 05, 2019
Sell 328 K USD
Carilion Clinic
10 percent owner
- 48953
6.71 USD
5 years ago
Sep 06, 2019
Sell 342 K USD
Carilion Clinic
10 percent owner
- 51047
6.7 USD
5 years ago
Aug 30, 2019
Sell 338 K USD
Carilion Clinic
10 percent owner
- 53265
6.35 USD
5 years ago
Sep 03, 2019
Sell 534 K USD
Carilion Clinic
10 percent owner
- 83634
6.39 USD
5 years ago
Aug 28, 2019
Sell 691 K USD
Carilion Clinic
10 percent owner
- 109604
6.3 USD
5 years ago
Aug 29, 2019
Sell 508 K USD
Carilion Clinic
10 percent owner
- 81796
6.21 USD
5 years ago
Aug 26, 2019
Sell 326 K USD
Carilion Clinic
10 percent owner
- 52220
6.25 USD
5 years ago
Aug 27, 2019
Sell 297 K USD
Carilion Clinic
10 percent owner
- 47780
6.22 USD
5 years ago
Aug 21, 2019
Sell 313 K USD
Carilion Clinic
Director
- 51699
6.06 USD
5 years ago
Aug 21, 2019
Sell 313 K USD
Carilion Clinic
10 percent owner
- 51699
6.06 USD
5 years ago
Aug 22, 2019
Sell 293 K USD
Carilion Clinic
Director
- 48301
6.07 USD
5 years ago
Aug 22, 2019
Sell 293 K USD
Carilion Clinic
10 percent owner
- 48301
6.07 USD
5 years ago
Aug 19, 2019
Sell 179 K USD
Carilion Clinic
10 percent owner
- 29768
6.02 USD
5 years ago
Aug 19, 2019
Sell 179 K USD
Carilion Clinic
Director
- 29768
6.02 USD
5 years ago
Aug 20, 2019
Sell 415 K USD
Carilion Clinic
Director
- 68732
6.04 USD
5 years ago
Aug 20, 2019
Sell 415 K USD
Carilion Clinic
10 percent owner
- 68732
6.04 USD
5 years ago
Aug 21, 2019
Sell 9.02 K USD
Carilion Clinic
Director
- 1500
6.01 USD
5 years ago
Aug 21, 2019
Sell 9.02 K USD
Carilion Clinic
10 percent owner
- 1500
6.01 USD
5 years ago
Aug 14, 2019
Sell 131 K USD
Carilion Clinic
10 percent owner
- 23336
5.62 USD
5 years ago
Aug 15, 2019
Sell 312 K USD
Carilion Clinic
10 percent owner
- 55969
5.57 USD
5 years ago
Aug 12, 2019
Sell 470 K USD
Carilion Clinic
10 percent owner
- 83861
5.61 USD
5 years ago
Aug 13, 2019
Sell 210 K USD
Carilion Clinic
10 percent owner
- 36834
5.7 USD
5 years ago
Aug 08, 2019
Sell 286 K USD
Carilion Clinic
10 percent owner
- 54495
5.25 USD
5 years ago
Jul 31, 2019
Sell 226 K USD
Carilion Clinic
10 percent owner
- 42200
5.35 USD
5 years ago
Aug 01, 2019
Sell 17.4 K USD
Carilion Clinic
10 percent owner
- 3305
5.25 USD
5 years ago
Jul 26, 2019
Sell 35.8 K USD
Carilion Clinic
10 percent owner
- 7154
5 USD
5 years ago
Jul 29, 2019
Sell 86.2 K USD
Carilion Clinic
10 percent owner
- 17178
5.02 USD
5 years ago
Jul 24, 2019
Sell 67.3 K USD
Carilion Clinic
10 percent owner
- 13466
5 USD
5 years ago
Jul 24, 2019
Sell 67.3 K USD
Carilion Clinic
Director
- 13466
5 USD
5 years ago
Jul 25, 2019
Sell 5.56 K USD
Carilion Clinic
Director
- 1113
5 USD
5 years ago
Jul 25, 2019
Sell 5.56 K USD
Carilion Clinic
10 percent owner
- 1113
5 USD
5 years ago
Jul 22, 2019
Sell 442 K USD
Carilion Clinic
10 percent owner
- 87960
5.02 USD
5 years ago
Jul 23, 2019
Sell 28 K USD
Carilion Clinic
10 percent owner
- 5590
5.01 USD
5 years ago
Jul 18, 2019
Sell 86 K USD
Carilion Clinic
10 percent owner
- 17196
5 USD
5 years ago
Jul 19, 2019
Sell 151 K USD
Carilion Clinic
10 percent owner
- 30208
5 USD
5 years ago
Jul 16, 2019
Sell 86.8 K USD
Carilion Clinic
10 percent owner
- 17300
5.02 USD
5 years ago
Jul 17, 2019
Sell 14.2 K USD
Carilion Clinic
10 percent owner
- 2835
5 USD
6 years ago
Jul 16, 2018
Sell 134 K USD
Carilion Clinic
10 percent owner
- 39497
3.4 USD
6 years ago
Jul 09, 2018
Sell 30.4 K USD
Carilion Clinic
10 percent owner
- 8955
3.4 USD
6 years ago
May 31, 2018
Sell 340 USD
Carilion Clinic
10 percent owner
- 100
3.4 USD
6 years ago
May 25, 2018
Sell 20.8 K USD
Carilion Clinic
10 percent owner
- 6100
3.41 USD
6 years ago
May 29, 2018
Sell 2.04 K USD
Carilion Clinic
10 percent owner
- 600
3.4 USD
6 years ago
May 21, 2018
Sell 3.11 K USD
Carilion Clinic
10 percent owner
- 915
3.4 USD
6 years ago
May 17, 2018
Sell 7.12 K USD
Carilion Clinic
10 percent owner
- 2095
3.4 USD
6 years ago
May 18, 2018
Sell 343 K USD
Carilion Clinic
10 percent owner
- 100835
3.4 USD
6 years ago
May 08, 2018
Sell 144 K USD
Carilion Clinic
10 percent owner
- 41854
3.44 USD
6 years ago
May 09, 2018
Sell 77.4 K USD
Carilion Clinic
10 percent owner
- 22754
3.4 USD
6 years ago
May 03, 2018
Sell 13.3 K USD
Carilion Clinic
10 percent owner
- 3900
3.4 USD
6 years ago
May 01, 2018
Sell 48.1 K USD
Carilion Clinic
10 percent owner
- 14103
3.41 USD
6 years ago
May 02, 2018
Sell 21.4 K USD
Carilion Clinic
10 percent owner
- 6275
3.41 USD
6 years ago
Apr 16, 2018
Sell 115 K USD
Carilion Clinic
10 percent owner
- 33700
3.41 USD
6 years ago
Apr 17, 2018
Sell 18.6 K USD
Carilion Clinic
10 percent owner
- 5472
3.4 USD
6 years ago
Apr 12, 2018
Sell 206 K USD
Carilion Clinic
10 percent owner
- 59980
3.43 USD
7. News
Luna Innovations Receives Additional Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q ROANOKE, Va.--(BUSINESS WIRE)--Luna Innovations Incorporated (Nasdaq: LUNA) (the “Company”), a global leader in advanced fiber optic-based technology, today announced that it has received a written notice (the “Notice”) on November 14, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the quarter ended September 30, 2024 (the “Q3 2024 Form 10-Q”) and because the Company remains delinque. businesswire.com - 1 day ago
Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements – Investor & analyst webcast, including a key opinion leader panel, to be held Monday, November 18 th at 7:30 a.m. EST globenewswire.com - 1 day ago
LUNA INNOVATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Luna Innovation, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Luna Innovation, Inc. (NASDAQ: LUNA) on behalf of long-term stockholders following a class action complaint that was filed against Luna Innovation on April 1, 2024 with a Class Period from August 11, 2023 to March 25, 2024. Our investigation concerns whether the board of directors of Luna Innovation have breached their fiduciary duties to the company. globenewswire.com - 3 weeks ago
Luna Innovations Announces CFO Transition: Names William Phelan as Chief Financial Officer and Chief Accounting Officer ROANOKE, Va.--(BUSINESS WIRE)-- #Leadership--Luna Innovations Incorporated (NASDAQ: LUNA), a global leader in advanced fiber optic-based technology, today announced the appointment of William L. Phelan as its new Chief Financial Officer and Chief Accounting Officer, effective immediately. Mr. Phelan succeeds John Roiko, who joined Luna out of retirement in May 2024 and played a key role in establishing a resilient foundation for Luna's future growth. Following the appointment of Mr. Phelan, Mr. Roiko will sh. businesswire.com - 1 month ago
Luna Innovations Announces Receipt of Nasdaq Staff Determination Letter ROANOKE, Va,--(BUSINESS WIRE)--Luna Innovations Incorporated (Nasdaq: LUNA) (the “Company”), a global leader in advanced fiber optic-based technology, today announced that on October 1, 2024, it received a staff determination letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to the Company's failure to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companie. businesswire.com - 1 month ago
LUNA INNOVATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Luna Innovation, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Luna Innovation, Inc. (NASDAQ: LUNA) on behalf of long-term stockholders following a class action complaint that was filed against Luna Innovation on April 1, 2024 with a Class Period from August 11, 2023 to March 25, 2024. Our investigation concerns whether the board of directors of Luna Innovation have breached their fiduciary duties to the company. globenewswire.com - 1 month ago
LUNA INNOVATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Luna Innovation, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Luna Innovation, Inc. (NASDAQ: LUNA) on behalf of long-term stockholders following a class action complaint that was filed against Luna Innovation on April 1, 2024 with a Class Period from August 11, 2023 to March 25, 2024. Our investigation concerns whether the board of directors of Luna Innovation have breached their fiduciary duties to the company. globenewswire.com - 1 month ago
NORWEGIAN CRUISE LINE® UNVEILS ITS NEXT CUTTING-EDGE VESSEL -THE ALL-NEW NORWEGIAN LUNA™ - Open for Sale Today, the Sister Ship to Norwegian Aqua™, Will Debut in March 2026 with Seven-Day Caribbean Voyages from the Cruise Capital of the World – Miami - - Norwegian Luna™ will 'Shine Brighter' with Celestial Hull Art Inspired by the Reflection of Moonlight on the Sea by Celebrated Street Artist – ELLE - MIAMI , Sept. 18, 2024 /PRNewswire/ -- Norwegian Cruise Line® (NCL), the innovator in global cruise travel, today unveiled and opened for sale the next evolution of its Prima Plus Class, the all-new Norwegian Luna™. prnewswire.com - 1 month ago
Adverum Biotechnologies Presents Positive Ixo-vec Clinical Data from the 26-Week Interim Analysis of the LUNA Phase 2 Trial at the 2024 ASRS Annual Meeting -   6E10 combined with local prophylaxis selected for Phase 3 pivotal trials, with a favorable safety profile and potential best-in-class product profile at 26 weeks globenewswire.com - 4 months ago
LUNA Stockholders: Robbins LLP is Investigating the Officers and Directors of Luna Innovations Incorporated; Contact the Firm for More Information SAN DIEGO, June 28, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors it is investigating the officers and directors of Luna Innovations Incorporated (NASDAQ: LUNA) to determine whether they violated securities laws and breached their fiduciary duties to shareholders in connection with financial reporting. Luna Innovations is a technology company that focuses on fiber optics. globenewswire.com - 4 months ago
Rags to Riches: 3 Nanotech Stocks That Could Make Early Investors Rich Business leaders often talk about thinking big. But when it comes to nanotech stocks, the future is all about focusing on the small things. investorplace.com - 4 months ago
Investors in Luna Innovations Incorporated Should Contact Levi & Korsinsky Before May 31, 2024 to Discuss Your Rights - LUNA NEW YORK, NY / ACCESSWIRE / May 31, 2024 / If you suffered a loss on your Luna Innovations Incorporated (NASDAQ:LUNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/luna-innovations-lawsuit-submission-form?prid=82389&wire=1 or contact Joseph E. Levi, Esq. accesswire.com - 5 months ago
8. Profile Summary

Luna Innovations Incorporated LUNA

image
COUNTRY US
INDUSTRY Hardware, Equipment & Parts
MARKET CAP $ 55.4 M
Dividend Yield 0.00%
Description Luna Innovations Incorporated develops, manufactures, and markets fiber optic test, measurement, and control products worldwide. The company offers optical test and measurement products, which include optical vector analyzer, optical backscatter reflectometers, and the Phoenix family of tunable lasers; and Hyperion sensing solution that enables full-spectrum data acquisition and flexible peak detect algorithms of fiber-bragg gratings (FBGs), long period FBGs, and fabry-perot sensors with low-latency access to data for closed loop feedback applications. It also provides polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; single frequency lasers; temperature and strain sensing products; ODiSI sensing solution, which provides distributed strain and temperature measurements; and Terametrix terahertz gauging and imaging products that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements, as well as distributed acoustic sensing intellectual property and products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.
Contact 301 1st Street, SW, Roanoke, VA, 24011 https://www.lunainc.com
IPO Date June 5, 2006
Employees 337
Officers Mr. William L. Phelan Chief Financial Officer & Chief Accounting Officer Dr. Kevin Ilcisin President, Chief Executive Officer & Director Ms. Allison L. Woody Senior Director of Administration Mr. Ryan H. Stewart Senior Vice President, General Counsel & Corporate Secretary Ms. Eva Hartmann Senior Vice President of Human Resources Mr. Thomas Oldemeyer Senior Vice President & MD of EMEA Mr. Will Denman Senior Vice President of Sales - North America